Exploratory/Developmental Research for World Trade Center Health Program Evidence-based Strategies to Improve Treatment Effectiveness, Diagnostic Practices, and Program Evaluation (R21) | RFA OH 25 001

Opportunity Information: Apply for RFA OH 25 001

This funding opportunity, RFA OH 25 001, is a discretionary grant program from the Centers for Disease Control and Prevention (CDC) through the National Institute for Occupational Safety and Health (NIOSH). It uses the NIH-style R21 mechanism to support exploratory and developmental research connected to the World Trade Center (WTC) Health Program, specifically focusing on practical, evidence-based ways to improve how WTC-related health conditions are diagnosed and treated, and how the program itself is evaluated. The overall purpose is to fund early-stage, high-potential ideas that address real-world uncertainty in diagnosis or treatment among people receiving monitoring and/or care under Subtitle C of the James Zadroga 9/11 Health and Compensation Act of 2010.

The core scientific driver behind the announcement is uncertainty: situations where clinicians, researchers, or the program do not yet have clear, validated answers about how best to identify WTC-related conditions, distinguish them from similar illnesses, or treat them effectively. The Zadroga Act highlights three broad research directions that frame this solicitation: (1) physical and mental health conditions that may be related to the September 11, 2001 attacks, (2) improving diagnosis of WTC-related health conditions where diagnostic uncertainty persists, and (3) improving treatment of WTC-related conditions where treatment uncertainty remains. Within those guardrails, the WTC Health Program is explicitly encouraging new and innovative approaches, including fresh interventions, tools, techniques, analytic methods, or models that could measurably improve clinical decision-making, patient outcomes, and program performance.

The program is aiming for a balanced portfolio of strong, feasible pilot projects that test the potential of new ideas and help determine whether larger, more definitive studies should follow. The R21 format is meant for the early and conceptual stages of research development, so proposals are expected to be exploratory and may have minimal or no preliminary data. Even so, the intent is not vague brainstorming; applicants should still propose a clear, well-justified approach for assessing feasibility and generating actionable signals about whether an intervention, diagnostic approach, or evaluation method can be scaled or refined. The announcement emphasizes the expectation that these projects will break new ground, extend prior discoveries in new directions, or adapt existing methods in novel ways that could have meaningful clinical impact for 9/11-exposed communities.

The scope of research areas is intentionally broad and includes clinical, screening, diagnostic, epidemiological, treatment, prevention, translation, and program evaluation. In practice, that means projects could range from piloting a new diagnostic pathway or screening strategy, to testing an intervention intended to improve symptom control or functional outcomes, to developing and validating tools that help clinicians make more consistent decisions, to designing evaluation methods that better measure whether the WTC Health Program is delivering effective care. Program evaluation is specifically named as a priority, signaling interest not only in biomedical and clinical innovation, but also in the systems, processes, and real-world effectiveness of services delivered to members.

The target populations for funded work are those directly served by the WTC Health Program: WTC responders, screening-eligible WTC survivors, and certified-eligible WTC survivors. In other words, the research should be anchored in the needs and realities of 9/11-exposed individuals who are eligible for monitoring and/or treatment through the program, and it should be designed in a way that can ultimately inform better care, better diagnostic practices, or stronger evidence on what works for these groups.

A notable theme in the announcement is health equity. Applicants are encouraged to incorporate health equity considerations into study design where feasible, and the solicitation expresses particular interest in research that can support future understanding of health effects in vulnerable or historically underrepresented groups exposed to the attacks and aftermath. The notice calls out minorities, women, children, and other potentially disadvantaged groups as areas of special interest, and it frames the need in practical terms: identifying at-risk groups, characterizing the health burden, and producing evidence that can inform care. This signals that proposals that thoughtfully address gaps in evidence for underserved subpopulations, or that test strategies to reduce disparities in diagnosis and treatment outcomes, are aligned with program priorities.

From an applicant standpoint, eligibility is broad. Eligible entities include various levels of government (state, county, city/township, special districts), independent school districts, public and private institutions of higher education, federally recognized tribal governments and other tribal organizations, public housing authorities, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), and the opportunity is listed as unrestricted. This wide eligibility suggests the program is open to academic, clinical, public health, community-based, and private-sector innovators, as long as the proposed work fits the WTC Health Program mission and the R21 exploratory intent.

Key administrative details provided include an original closing date of 2024-10-29, an expected number of awards of 8, and the CFDA number 93.262. The award ceiling is listed as 0, which typically indicates the ceiling is not specified in the summary fields rather than implying unlimited funding; applicants would need to confirm budget limits and R21 constraints in the full notice. The funding instrument is a grant, and the activity category is health.

Finally, the announcement points applicants toward the WTC Health Program Research webpage as a central hub for planning and context. That site includes the program research agenda, a publication library, and practical tools like the Funding Dashboard, which lists prior awarded projects and details such as topics, populations studied, funding amounts, and the investigators and institutions involved. The clear message is that applicants should use existing program resources to understand what has already been funded, where the evidence gaps remain, and how a proposed exploratory R21 study can add something genuinely new and useful to improve diagnosis, treatment effectiveness, and evaluation for 9/11-exposed populations.

• The Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Exploratory/Developmental Research for World Trade Center Health Program Evidence-based Strategies to Improve Treatment Effectiveness, Diagnostic Practices, and Program Evaluation (R21)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.262.
• This funding opportunity was created on 2024-05-09.
• Applicants must submit their applications by 2024-10-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 8 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Unrestricted.

Apply for RFA OH 25 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: